IN2014CN04449A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN04449A IN2014CN04449A IN4449CHN2014A IN2014CN04449A IN 2014CN04449 A IN2014CN04449 A IN 2014CN04449A IN 4449CHN2014 A IN4449CHN2014 A IN 4449CHN2014A IN 2014CN04449 A IN2014CN04449 A IN 2014CN04449A
- Authority
- IN
- India
- Prior art keywords
- present
- hiv
- compounds
- useful
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/52—Ortho- or ortho- and peri-condensed systems containing five condensed rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011002105 | 2011-12-14 | ||
| PCT/CN2011/002159 WO2013091144A1 (en) | 2011-12-21 | 2011-12-21 | Propenoate derivatives of betulin |
| PCT/US2012/069688 WO2013090683A1 (en) | 2011-12-14 | 2012-12-14 | Propenoate derivatives of betulin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN04449A true IN2014CN04449A (es) | 2015-09-04 |
Family
ID=48613201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4449CHN2014 IN2014CN04449A (es) | 2011-12-14 | 2012-12-14 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9340513B2 (es) |
| EP (1) | EP2791102B1 (es) |
| JP (1) | JP6091520B2 (es) |
| KR (1) | KR20140101869A (es) |
| CN (1) | CN104271550B (es) |
| AU (1) | AU2012352129B2 (es) |
| BR (1) | BR112014014046A2 (es) |
| CA (1) | CA2859032A1 (es) |
| ES (1) | ES2584684T3 (es) |
| IN (1) | IN2014CN04449A (es) |
| RU (1) | RU2613554C2 (es) |
| WO (1) | WO2013090683A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3387B1 (ar) | 2011-12-16 | 2019-03-13 | Glaxosmithkline Llc | مشتقات بيتولين |
| JP2016503030A (ja) | 2012-12-14 | 2016-02-01 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ | 医薬組成物 |
| WO2014105926A1 (en) | 2012-12-31 | 2014-07-03 | Hetero Research Foundation | Novel betulinic acid proline derivatives as hiv inhibitors |
| US20170129916A1 (en) | 2014-06-26 | 2017-05-11 | Hetero Research Foundation | Novel betulinic proline imidazole derivatives as hiv inhibitors |
| PE20170691A1 (es) | 2014-09-26 | 2017-06-13 | Glaxosmithkline Intellectual Property (No 2) Ltd | Composiciones farmaceuticas de accion prolongada |
| KR20170092580A (ko) * | 2014-11-14 | 2017-08-11 | 비브 헬스케어 유케이 (넘버5) 리미티드 | 연장된 베툴린산 유사체 |
| MA40886B1 (fr) | 2015-02-09 | 2020-03-31 | Hetero Research Foundation | Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih |
| US10370405B2 (en) | 2015-03-16 | 2019-08-06 | Hetero Labs Limited | C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors |
| WO2019150300A1 (en) | 2018-02-02 | 2019-08-08 | Glaxosmithkline Intellectual Property (No.2) Limited | Crystalline forms of 4-(((3ar,5ar,5br,7ar,9s,11ar,11br,13as)-3a-((r)-2-((4-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-1-hydroxyethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2h-cyclopenta[a]chrysen-9-yl)oxy)-2,2-dimethyl-4-oxobutanoic acid |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200628161A (en) * | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| TW200837074A (en) * | 2006-11-03 | 2008-09-16 | Panacos Pharmaceuticals Inc | Extended triterpene derivatives |
| WO2009073818A1 (en) | 2007-12-04 | 2009-06-11 | Myriad Genetics, Inc. | Compounds and therapeutic use thereof |
| EP2250185A4 (en) * | 2008-01-03 | 2011-11-16 | Virochem Pharma Inc | NEW LUPANDERIVATE |
| CN101328201A (zh) * | 2008-07-29 | 2008-12-24 | 浙江大学 | 一种从桦树皮中提取白桦脂醇的方法 |
| US8802727B2 (en) | 2009-07-14 | 2014-08-12 | Hetero Research Foundation, Hetero Drugs Limited | Pharmaceutically acceptable salts of betulinic acid derivatives |
| US9067966B2 (en) * | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
| CN101709322B (zh) * | 2009-11-26 | 2012-06-27 | 浙江大学 | 生物催化白桦脂醇合成白桦脂酸的方法 |
| CN101704874A (zh) * | 2009-11-26 | 2010-05-12 | 中国药科大学 | 五环三萜及其衍生物的二甲双胍盐、其制备方法及医药用途 |
| WO2011100308A1 (en) * | 2010-02-11 | 2011-08-18 | Glaxosmithkline Llc | Derivatives of betulin |
-
2012
- 2012-12-14 US US14/364,409 patent/US9340513B2/en not_active Expired - Fee Related
- 2012-12-14 IN IN4449CHN2014 patent/IN2014CN04449A/en unknown
- 2012-12-14 RU RU2014122866A patent/RU2613554C2/ru not_active IP Right Cessation
- 2012-12-14 WO PCT/US2012/069688 patent/WO2013090683A1/en active Application Filing
- 2012-12-14 BR BR112014014046A patent/BR112014014046A2/pt not_active Application Discontinuation
- 2012-12-14 ES ES12856832.6T patent/ES2584684T3/es active Active
- 2012-12-14 EP EP12856832.6A patent/EP2791102B1/en active Active
- 2012-12-14 JP JP2014547472A patent/JP6091520B2/ja not_active Expired - Fee Related
- 2012-12-14 CA CA2859032A patent/CA2859032A1/en not_active Abandoned
- 2012-12-14 KR KR1020147019366A patent/KR20140101869A/ko active IP Right Grant
- 2012-12-14 CN CN201280069633.7A patent/CN104271550B/zh not_active Expired - Fee Related
- 2012-12-14 AU AU2012352129A patent/AU2012352129B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012352129A1 (en) | 2014-08-07 |
| AU2012352129B2 (en) | 2016-02-04 |
| RU2014122866A (ru) | 2016-02-10 |
| US9340513B2 (en) | 2016-05-17 |
| EP2791102A1 (en) | 2014-10-22 |
| US20140350032A1 (en) | 2014-11-27 |
| RU2613554C2 (ru) | 2017-03-17 |
| KR20140101869A (ko) | 2014-08-20 |
| CN104271550A (zh) | 2015-01-07 |
| ES2584684T3 (es) | 2016-09-28 |
| JP2015501846A (ja) | 2015-01-19 |
| BR112014014046A2 (pt) | 2017-06-13 |
| CA2859032A1 (en) | 2013-06-20 |
| CN104271550B (zh) | 2016-09-07 |
| JP6091520B2 (ja) | 2017-03-08 |
| WO2013090683A1 (en) | 2013-06-20 |
| EP2791102B1 (en) | 2016-05-18 |
| EP2791102A4 (en) | 2015-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017501426A1 (en) | Derivatives of betulin | |
| EA201290632A1 (ru) | Производные бетулина | |
| IN2014CN04449A (es) | ||
| MD20180040A2 (ro) | Inhibitori ai virusului hepatic C | |
| TN2014000122A1 (en) | 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases | |
| MY164776A (en) | Heterocyclic compound | |
| MX2016006336A (es) | Compuestos pirazolopirimidina. | |
| AU2012313888A8 (en) | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH | |
| MY165087A (en) | Neprilysin inhibitors | |
| MY163394A (en) | Substituted aminobutyric derivates as neprilysin inhibitors | |
| MX2015005286A (es) | Procedimiento para la preparación de derivados del ácido biliar. | |
| TN2014000095A1 (en) | Pharmaceutical compositions | |
| MY187718A (en) | Pharmaceutical formulations | |
| IN2014MN01521A (es) | ||
| MX364400B (es) | Compuestos de tetraciclina. | |
| IN2014DN07996A (es) | ||
| MX2013000294A (es) | Intermedios y procedimiento de preparación de un inhibidor específico de la trombina. | |
| MX2014004688A (es) | Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos. | |
| MX359399B (es) | Inhibidores de 17alfa-hidroxilasa/c17-20-liasa. | |
| SG10201901578UA (en) | Processes for the preparation of pyrimidinylcyclopentane compounds | |
| MX2013002656A (es) | Nuevo proceso. | |
| IN2013CN00515A (es) | ||
| JO3723B1 (ar) | مركبات دائرية مغايرة |